Compound information
- Natural Products
- ZC100273
- Molecular Formula
- C15H20O4
- Molecular Weight
- 264.13615912 g/mol
- Structure
-
- IUPAC Name
- (1R,2S,5S)-1,5-dihydroxy-2-(hydroxymethyl)-2,5,7-trimethyl-spiro[1H-indene-6,1'-cyclopropane]-4-one
- InChI
- InChI=1S/C15H20O4/c1-8-10-9(6-13(2,7-16)12(10)18)11(17)14(3,19)15(8)4-5-15/h6,12,16,18-19H,4-5,7H2,1-3H3/t12-,13+,14-/m1/s1
- InChI Key
- DDLLIYKVDWPHJI-HZSPNIEDSA-N
- SMILES
- CC1=C2C(=C[C@@](C)(CO)[C@@H]2O)C(=O)[C@@](C)(O)C12CC2
- Source
- ZINC000005766705
Warheads
- Michael Acceptor
-
- Cyclopropane
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 19 | Ring Count | 3 |
| Heteroatom Count | 4 | Rotatable Bond Count | 1 |
| Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
| Topological Polar Surface Area | 77.76 Å2 | LogP | 0.542 |
| LogS | -2.374 | LogD | 0.967 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.017 | Pgp substrate | 0.005 |
| HIA | 0.966 | F20 % | 0.946 |
| F30 % | 0.595 | Caco-2 | -4.636 |
| MDCK | -4.597 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.932 | PPB | 36.07 |
| VD | 1.867 | Fu | 0.199 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.024 | CYP1A2 substrate | 0.355 |
| CYP2A6 substrate | 0.375 | CYP2B6 substrate | 0.383 |
| CYP2C19 inhibitor | 0.066 | CYP2C19 substrate | 0.452 |
| CYP2C8 substrate | 0.493 | CYP2C9 inhibitor | 0.003 |
| CYP2C9 substrate | 0.04 | CYP2D6 inhibitor | 0.007 |
| CYP2D6 substrate | 0.174 | CYP2E1 substrate | 0.516 |
| CYP3A4 inhibitor | 0.132 | CYP3A4 substrate | 0.117 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.352 | CL | 3.886 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.0 | Hepatotoxicity | 0.902 |
| Mutagenicity | 0.999 | Rat Oral Acute Toxicity | 0.176 |
| FDAMDD | 0.313 | Skin Sensitization | 0.779 |
| Carcinogenicity | 0.417 | Eye Corrosion | 0.835 |
| Eye Irritation | 0.736 | Respiratory Toxicity | 0.379 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.235 | IGC50 | 2.815 |
| LC50FM | 1.711 | LC50DM | 4.649 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.546 | NR-AR-LBD | 0.808 |
| NR-AhR | 0.136 | NR-Aromatase | 0.942 |
| NR-ER | 0.344 | NR-ER-LBD | 0.561 |
| NR-PPAR-gamma | 0.686 | SR-ARE | 0.752 |
| SR-ATAD5 | 0.583 | SR-HSE | 0.216 |
| SR-MMP | 0.712 | SR-p53 | 0.807 |
Similar covalent inhibitors
No similar covalent inhibitors found for this compound.
Similar covalent drugs
No similar covalent drugs found for this compound.